Poolbeg Pharma PLC POLBF
0.10 USD 0.00 (+0.00%)
At closeNov 4, 2026, 4:00 PM EST
0.095 Day range 0.0958
0.0425 52-week range 0.1154
- YTD
- +125.41%
- 1 year
- +125.41%
- Market cap
- 73.14M
- EPS (ttm)
- -0.010341
- P/E ratio
- -9.26
- YTD return
- +125.41%
- 1-year return
- +125.41%
- Volume
- 10.00K
- Avg volume
- 5.83K
- Open
- 0.095
- Previous close
- 0.0958
- Day's range
- 0.095 – 0.0958
- 52-week range
- 0.0425 – 0.1154
2Y -0.0552 (-36.56%)
News
Poolbeg Pharma's Korean patent grant bolsters Cavendish's ‘buy' case 
Poolbeg secures South Korean cancer immunotherapy-induced CRS patent 
Poolbeg Pharma retains ‘buy' rating at Cavendish after safety review allows trial to continue 
Poolbeg Pharma funded to finish both trials as it courts partners for cancer drug 
Poolbeg Pharma doses eight patients in cancer side-effect trial 
Poolbeg Pharma PLC (POLBF) Shareholder/Analyst Call Transcript 
Poolbeg Pharma trial progress strengthens Cavendish case for 19p target 
Poolbeg Pharma gets green light to continue clinical trial 
Poolbeg wins Israeli patent nod for lead cancer immunotherapy drug 
Poolbeg Pharma raises £3.5m to support key trial and GLP-1 progress
Your note
Sign in to keep a note on POLBF — it syncs with the Stock Master app.